Disintegrin variant and pharmaceutical use thereof

Disintegrin variant and pharmaceutical use thereof

  • CN 101,677,537 B
  • Filed: 12/21/2007
  • Issued: 08/17/2016
  • Est. Priority Date: 12/26/2006
  • Status: Active Grant
First Claim
Patent Images

1. pair α

  • v β

    3 integrin has selective polypeptide or the pharmaceutically acceptable salt of described polypeptide, wherein said polypeptideFor rhodostomin variant, wherein said rhodostomin variant is by selected from SEQ ID NO;

    57-69Aminoacid sequence composition.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×